Awad, Mark M.
Dana-Farber Cancer Institute,
United States
2025 Rank: 76021
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3051 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76021 | 83833 |
| Total Cites | 20040 | 21815 |
| H-index | 64 | 67 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 40 | 41 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 2569 | 2773 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 4997 | 5474 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15798 | 16772 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.30 |
| Self-Citation Percentage |
8.14%
|
|
Awad, Mark M.
Dana-Farber Cancer Institute,
United States
2024 Rank: 87079
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3473 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87079 | 95909 |
| Total Cites | 15934 | 17387 |
| H-index | 59 | 62 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 39 | 40 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 2103 | 2283 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 3900 | 4294 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12651 | 13476 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
8.36%
|
|
Awad, Mark M.
Dana-Farber Cancer Institute,
United States
2023 Rank: 106900
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4179 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106900 | 118109 |
| Total Cites | 12310 | 13475 |
| H-index | 52 | 54 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 36 | 37 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1708 | 1872 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 3001 | 3305 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9860 | 10549 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
8.65%
|
|
Awad, Mark M.
Dana-Farber Cancer Institute,
United States
2022 Rank: 130558
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4983 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130558 | 141670 |
| Total Cites | 9135 | 10044 |
| H-index | 45 | 48 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 32 | 33 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1343 | 1494 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 2214 | 2452 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7367 | 7923 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
9.05%
|
|
Awad, Mark M.
Dana-Farber Cancer Institute,
United States
2021 Rank: 140614
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5338 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 140614 | 150487 |
| Total Cites | 7802 | 8625 |
| H-index | 42 | 46 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 31 | 32 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 1213 | 1354 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 1945 | 2164 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6328 | 6832 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
9.54%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.